Brought to you by 
Pervasis Therapeutics completes $17.4mm Series B round
23 Jan 2007
Executive Summary
Pervasis Therapeutics (developing cardiovascular drug candidates) has raised $17.4mm with its Series B venture round. New investor Highland Capital Partners led the round and was joined by current backers Polaris Venture Partners and Flagship Venture Partners.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com